dc.contributor.author |
Kántor Orsolya |
|
dc.contributor.author |
Molnár Judith |
|
dc.contributor.author |
Arimura A |
|
dc.contributor.author |
Köves Katalin |
|
dc.date.accessioned |
2015-03-09T09:35:33Z |
|
dc.date.available |
2015-03-09T09:35:33Z |
|
dc.date.issued |
2000 |
|
dc.identifier.citation |
pagination=817-820;journalVolume=21;journalIssueNumber=6;journalTitle=PEPTIDES; |
hu |
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/1417 |
|
dc.identifier.uri |
doi:10.1016/S0196-9781(00)00214-X |
|
dc.description.abstract |
The effect of PACAP38 on the LH surge and ovulation was compared
with that of PACAP27 and VIP in the same model. The peptides
were administered intracerebroventricularly before the critical
period of the proestrous stage. PACAP38 was able to inhibit
ovulation and to prevent the preovulatory LH surge; however,
PACAP27 did not inhibit the ovulation and VIP inhibited the
ovulation in 2/11 animals. In those animals of the last two
groups in which ovulation occurred, the preovulatory LH surge
was higher than in control rats. It is speculated that the
opposite effect of PACAP38 and PACAP27 on the preovulatory LH
surge and ovulation is possibly mediated through different
receptors. |
hu |
dc.relation.ispartof |
urn:issn:0196-9781 |
|
dc.title |
PACAP38 and PACAP27 administered intracerebroventricularly have an opposite effect on LH secretion |
hu |
dc.type |
Journal Article |
hu |
dc.date.updated |
2015-02-16T12:44:34Z |
|
dc.language.rfc3066 |
en |
hu |
dc.identifier.mtmt |
1871389 |
|
dc.identifier.wos |
000089066400010 |
|
dc.identifier.pubmed |
10959003 |
|
dc.contributor.department |
SE/AOK/I/Humánmorfológiai és Fejlődésbiológiai Intézet |
|
dc.contributor.institution |
Semmelweis Egyetem |
|